Results 191 to 200 of about 46,072 (254)
Alpinia oxyphylla Miq. (AOM), a medicinal and edible resource, contains diphenylheptanoids, polysaccharides, flavonoids, terpenoids, and phenolic acids. These constituents exert multi‐target synergistic effects by modulating neuroinflammation, oxidative stress, and the PI3K/Akt pathway, thereby improving Alzheimer's disease, Parkinson's disease, and ...
Ziyan Yang +5 more
wiley +1 more source
The role of sphingolipids in major depressive disorder and associated cognitive impairment: interactions with monoaminergic signaling, neuroinflammation, and neurogenesis. [PDF]
Hoertel N +8 more
europepmc +1 more source
Extracellular Vesicles for Space Biomedical Research
Microgravity reshapes EV biogenesis and cargo selection, which brings new opportunities for longitudinal liquid‐biopsy readouts of stress and aging‐like trajectories, as well as the regenerative products in spaceflight research. ABSTRACT Extracellular vesicles (EVs) are regulated, information‐rich nanovesicles that reflect aspects of parent‐cell state,
Samantha Ali +10 more
wiley +1 more source
Measles virus reprograms CD4<sup>+</sup> T-cell sphingolipid and fatty acid metabolism to facilitate infection. [PDF]
Grijalva Yépez MF +5 more
europepmc +1 more source
Cells are wrapped in a double‐sided plasma membrane made up of fatty lipids that can release lipid‐wrapped fragments called extracellular vesicles (EVs). Diverse scramblase proteins, which shuffle lipids across cellular membranes in both directions, can promote EV release.
Bianca L. Guerra +7 more
wiley +1 more source
Matrix Vesicle‐Associated SMS2 as a Novel Mediator of Biomineralization
ABSTRACT SGMS2, a gene encoding plasma membrane‐resident sphingomyelin synthase 2, SMS2, has emerged as an important determinant of skeletal ossification. Heterozygous SGMS2 variants are associated with a broad spectrum of bone phenotypes, ranging from rickets‐like deformities in childhood to early‐onset osteoporosis, implicating SMS2 in mineralization
Phillip T. Newton +4 more
wiley +1 more source
The Liver as the Central Regulator of Cholesterol Homeostasis: Statins, Gut Microbiota, Hepatic Inflammation, and the Proposed Oral-Gut-Liver-Artery Axis in Atherogenesis. [PDF]
Cannon M, Peldyak J, Campbell E.
europepmc +1 more source

